Excitement Builds for Long-Acting TB Treatments, but Research Still at Early Stage

25 March 2025

Both TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working on new long-acting formulations that might, for example, reduce an entire course of TB preventive therapy to a single injection. Data on long-acting TB drugs was presented at the 32nd Conference on Retroviruses and Opportunistic Infections (CROI 2025) held in San Francisco, US, on 9-12 March 2025.

Read the full news story at Spotlight.